Economic contributions of pharmaceutical interventions by pharmacists: a retrospective report in Japan

[1]  J. Sakurai.  PMDA (Pharmaceuticals and Medical Devices Agency) , 2014 .

[2]  Yuichi Tasaka,et al.  Estimation of the Economic Impact Associated with Pharmaceutical Interventions , 2014 .

[3]  隆 丹羽.  抗菌薬適正使用推進プログラム（Antimicrobial Stewardship）の完全実施体制の確立とアウトカム評価 , 2013 .

[4]  K. Masuyama.  [Pharmaceuticals and Medical Devices Agency (PMDA)'s new action for Pharmaceutical Affairs Consultation on Research and Development (R&D) Strategy]. , 2013, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[5]  Kelli A. Rumbaugh,et al.  Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: An evidence-based approach , 2012, The journal of trauma and acute care surgery.

[6]  A. Pereira,et al.  Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta‐analysis , 2012, Pharmacoepidemiology and drug safety.

[7]  K. Negishi,et al.  [Medical economics research on awareness of community pharmacists about raising pharmaceutical questions regarding prescriptions issued by physicians]. , 2012, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[8]  K. Negishi,et al.  [Survey on the awareness of community pharmacists about raising pharmaceutical questions regarding prescriptions issued by physicians]. , 2011, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[9]  Naohito Ide,et al.  [Proposal for a new tool to evaluate clinical pharmacy practice based on the percentage of pharmaceutical interventions that influence medical treatments]. , 2008, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[10]  B. Franklin,et al.  A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay , 2006, BMC infectious diseases.

[11]  C. Raehl,et al.  Adverse Drug Reactions in United States Hospitals , 2006, Pharmacotherapy.

[12]  I. Yano,et al.  Evaluation of Providing Drug Information and Clinical Pharmacy Intervention Undertaken in Hospital Pharmaceutical Care , 2003 .

[13]  D. Suh,et al.  Clinical and Economic Impact of Adverse Drug Reactions in Hospitalized Patients , 2000, The Annals of pharmacotherapy.

[14]  N. Kaplan.  Guidelines for the management of hypertension. , 2000, The Canadian journal of cardiology.

[15]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[16]  S D Small,et al.  The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. , 1998, JAMA.

[17]  D. Classen,et al.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.

[18]  D. Bates,et al.  The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .